Robert Andrew Berman insider trades

Open-market stock purchases and sales by Robert Andrew Berman, Chief Executive Officer at enVVeno Medical Corp, from SEC Form 4 filings since Jan 25, 2013.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +79%.

Recent trades

DateStockTradeValue
Dec 16, 2025NVNO enVVeno Medical CorpSold (not open market)—

Companies traded

  • NVNO enVVeno Medical Corp: 4 buys, last Dec 16, 2025
  • HJLI Hancock Jaffe Laboratories, Inc: 3 buys, last May 18, 2021
  • ITUS ITUS Corp: 15 buys, last Jun 2, 2017
  • ITUSD ITUS Corp: 6 buys, last Jul 10, 2015
  • COPY Copytele Inc: 18 buys, last Jan 29, 2014

Get free alerts when Robert Andrew Berman files a new trade →